NS
Nancy Stuart
Chief Operating Officer

Nancy Stuart insider trades: Concert Pharmaceuticals (CNCE) stock sales

Chief Operating Officer, Concert Pharmaceuticals Last trade Feb 15, 2023 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2015
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nancy reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 15, 2023CNCE↓ Sell$50K
Jan 30, 2023CNCE↓ Sell$110K
Jan 6, 2023CNCE↓ Sell$21K
Feb 14, 2022CNCE↓ Sell$19K
Jan 5, 2022CNCE↓ Sell$9K
Feb 16, 2021CNCE↓ Sell$44K
Jun 22, 2020CNCE↓ Sell$117K
Jul 10, 2018CNCE↓ Sell$562K
Nov 2, 2015CNCE↓ Sell$564K
Mar 11, 2015CNCE↓ Sell$696K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Nancy Stuart's insider trades

Nancy Stuart is Chief Operating Officer at Concert Pharmaceuticals (CNCE). Since Mar 11, 2015, Nancy has reported no open-market purchases and 10 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), option exercises (12 filings), shares withheld for taxes (10 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.